Position Statement on In-hospital/Clinic Point-of-care Coagulation Testing for Anticoagulation Monitoring in Saudi Arabia.

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of the Saudi Heart Association Pub Date : 2023-11-06 eCollection Date: 2023-01-01 DOI:10.37616/2212-5043.1355
Fakhr Al Ayoubi, Malak Al Mashali, Mohamed H Abdallah, Mohamed Al Sheef, Tarek Owaidah
{"title":"Position Statement on In-hospital/Clinic Point-of-care Coagulation Testing for Anticoagulation Monitoring in Saudi Arabia.","authors":"Fakhr Al Ayoubi, Malak Al Mashali, Mohamed H Abdallah, Mohamed Al Sheef, Tarek Owaidah","doi":"10.37616/2212-5043.1355","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Hospital overload is a persistent occurrence in daily practice. Interventions such as point-of-care testing (POCT) are needed to alleviate the pressure faced by healthcare providers and administrators.</p><p><strong>Methods: </strong>An invited panel of experts from Saudi Arabia was formed under the auspices of the Saudi Heart Association in order to discuss local treatment gaps in the management of patients receiving anticoagulation therapy. This was done in a series of meetings, which resulted in the development of official recommendations for the implementation of POCT for anticoagulation monitoring in the country. Recommendations were based on a comprehensive literature review and international guidelines taking into consideration local clinical practice, clinical gaps, and treatment/testing availabilities.</p><p><strong>Results: </strong>Vitamin K antagonist (VKA)-based anticoagulation therapy requires routine monitoring. POCT is a promising model of care for the monitoring of International Normalized Ratio (INR) in patients receiving oral anticoagulation in terms efficacy, safety and convenience. The availability of POC INR testing should not replace the use of standard laboratory anticoagulation monitoring. However, there are several indications for implementing POCTINR monitoring that was agreed upon by the expert panel. POCT for anticoagulation monitoring should primarily be used in the warfarin (or other VKA) monitoring clinic in order to ensure treatment efficiency, cost-effectiveness of care, patient satisfaction, and quality of life improvement. The expert panel detailed the requirements for the establishment of a warfarin (or other VKA) monitoring clinic in terms of organization, safety, quality control, and other logistic and technical considerations. The limitations of POCT should be recognized and recommendations on best practices should be strictly followed. Core laboratory confirmation should be sought for patients with higher INR results (>4.7) on POCT. Proper training, quality control, and regulatory oversight are also critical for preserving the accuracy and reliability of POCT results.</p><p><strong>Conclusions: </strong>POCT enables more rapid clinical decision-making in the process of diagnosis (rule-in or rule-out), treatment choice and monitoring, and prognosis, as well as operational decision-making and resource utilization. POCT thus can fulfill an important role in clinical practice, particularly for patients receiving VKAs.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"35 4","pages":"290-300"},"PeriodicalIF":0.7000,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727136/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Saudi Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37616/2212-5043.1355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Hospital overload is a persistent occurrence in daily practice. Interventions such as point-of-care testing (POCT) are needed to alleviate the pressure faced by healthcare providers and administrators.

Methods: An invited panel of experts from Saudi Arabia was formed under the auspices of the Saudi Heart Association in order to discuss local treatment gaps in the management of patients receiving anticoagulation therapy. This was done in a series of meetings, which resulted in the development of official recommendations for the implementation of POCT for anticoagulation monitoring in the country. Recommendations were based on a comprehensive literature review and international guidelines taking into consideration local clinical practice, clinical gaps, and treatment/testing availabilities.

Results: Vitamin K antagonist (VKA)-based anticoagulation therapy requires routine monitoring. POCT is a promising model of care for the monitoring of International Normalized Ratio (INR) in patients receiving oral anticoagulation in terms efficacy, safety and convenience. The availability of POC INR testing should not replace the use of standard laboratory anticoagulation monitoring. However, there are several indications for implementing POCTINR monitoring that was agreed upon by the expert panel. POCT for anticoagulation monitoring should primarily be used in the warfarin (or other VKA) monitoring clinic in order to ensure treatment efficiency, cost-effectiveness of care, patient satisfaction, and quality of life improvement. The expert panel detailed the requirements for the establishment of a warfarin (or other VKA) monitoring clinic in terms of organization, safety, quality control, and other logistic and technical considerations. The limitations of POCT should be recognized and recommendations on best practices should be strictly followed. Core laboratory confirmation should be sought for patients with higher INR results (>4.7) on POCT. Proper training, quality control, and regulatory oversight are also critical for preserving the accuracy and reliability of POCT results.

Conclusions: POCT enables more rapid clinical decision-making in the process of diagnosis (rule-in or rule-out), treatment choice and monitoring, and prognosis, as well as operational decision-making and resource utilization. POCT thus can fulfill an important role in clinical practice, particularly for patients receiving VKAs.

关于沙特阿拉伯用于抗凝监测的院内/诊所床旁凝血检测的立场声明。
目的:医院负荷过重是日常工作中经常出现的问题。需要采取护理点检测(POCT)等干预措施来减轻医疗服务提供者和管理者面临的压力:在沙特心脏协会的支持下,沙特阿拉伯成立了一个特邀专家小组,以讨论当地在管理接受抗凝治疗的患者方面存在的治疗差距。通过召开一系列会议,最终为在该国实施 POCT 抗凝监测制定了官方建议。这些建议以全面的文献综述和国际指南为基础,并考虑了当地的临床实践、临床差距以及治疗/检测的可用性:结果:以维生素 K 拮抗剂 (VKA) 为基础的抗凝疗法需要常规监测。就疗效、安全性和便利性而言,POCT 是监测口服抗凝药患者国际标准化比值(INR)的一种很有前途的护理模式。POC INR 检测的可用性不应取代标准实验室抗凝监测的使用。不过,专家小组一致认为,POCTINR 监测有几个适应症。POCT 抗凝监测应主要用于华法林(或其他 VKA)监测门诊,以确保治疗效率、护理成本效益、患者满意度和生活质量的改善。专家小组从组织、安全、质量控制以及其他后勤和技术方面详细介绍了建立华法林(或其他 VKA)监测门诊的要求。应认识到 POCT 的局限性,并严格遵守有关最佳实践的建议。对于 POCT INR 结果较高(>4.7)的患者,应寻求核心实验室的确认。适当的培训、质量控制和监管对于保持 POCT 结果的准确性和可靠性也至关重要:结论:POCT 能够在诊断(排除或排除)、治疗选择和监测、预后以及操作决策和资源利用过程中更快速地做出临床决策。因此,POCT 可以在临床实践中发挥重要作用,尤其是对接受 VKA 的患者而言。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the Saudi Heart Association
Journal of the Saudi Heart Association CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.40
自引率
0.00%
发文量
30
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信